Unknown

Dataset Information

0

Synthesis, molecular docking, and in silico ADME/Tox profiling studies of new 1-aryl-5-(3-azidopropyl)indol-4-ones: Potential inhibitors of SARS CoV-2 main protease.


ABSTRACT: The virus SARS CoV-2, which causes the respiratory infection COVID-19, continues its spread across the world and to date has caused more than a million deaths. Although COVID-19 vaccine development appears to be progressing rapidly, scientists continue the search for different therapeutic options to treat this new illness. In this work, we synthesized five new 1-aryl-5-(3-azidopropyl)indol-4-ones and showed them to be potential inhibitors of the SARS CoV-2 main protease (3CLpro). The compounds were obtained in good overall yields and molecular docking indicated favorable binding with 3CLpro. In silico ADME/Tox profile of the new compounds were calculated using the SwissADME and pkCSM-pharmacokinetics web tools, and indicated adequate values of absorption, distribution and excretion, features related to bioavailability. Moreover, low values of toxicity were indicated for these compounds. And drug-likeness levels of the compounds were also predicted according to the Lipinski and Veber rules.

SUBMITTER: Dominguez-Villa FX 

PROVIDER: S-EPMC7683933 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Synthesis, molecular docking, and in silico ADME/Tox profiling studies of new 1-aryl-5-(3-azidopropyl)indol-4-ones: Potential inhibitors of SARS CoV-2 main protease.

Domínguez-Villa Francisco Xavier FX   Durán-Iturbide Noemi Angeles NA   Ávila-Zárraga José Gustavo JG  

Bioorganic chemistry 20201124


The virus SARS CoV-2, which causes the respiratory infection COVID-19, continues its spread across the world and to date has caused more than a million deaths. Although COVID-19 vaccine development appears to be progressing rapidly, scientists continue the search for different therapeutic options to treat this new illness. In this work, we synthesized five new 1-aryl-5-(3-azidopropyl)indol-4-ones and showed them to be potential inhibitors of the SARS CoV-2 main protease (3CLpro). The compounds w  ...[more]

Similar Datasets

| S-EPMC7346235 | biostudies-literature
| S-EPMC7670485 | biostudies-literature
| S-EPMC6443786 | biostudies-literature
| S-EPMC8619670 | biostudies-literature
| S-EPMC7677930 | biostudies-literature
| S-EPMC9355056 | biostudies-literature
| S-EPMC8173495 | biostudies-literature
| S-EPMC9153225 | biostudies-literature
| S-EPMC11279828 | biostudies-literature
| S-EPMC6685181 | biostudies-literature